Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma
Tóm tắt
Tumor lysis syndrome is a set of life threatening complication that can arise from treatment of high tumor burden, drug sensitive, and rapidly proliferating neoplasm particularly of hematological origin. It is rarely described in patients with solid tumors. We report the first case of tumor lysis syndrome in a man with metastatic renal pelvic transitional cell carcinoma after gemcitabine treatment. Despite aggressive therapy, he died 2 weeks after TLS was diagnosed. Our experience demonstrates that administration of gemcitabine for metastatic renal pelvic transitional cell carcinoma may induce acute tumor lysis syndrome, which necessitates frequent laboratory monitoring and prompt initiation of appropriate therapeutic measures.
Tài liệu tham khảo
Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004;127:3–11.
Baeksgaard L, Sorensen JB. Acute tumor lysis syndrome in solid tumors–a case report and review of the literature. Cancer Chemother Pharmacol 2003;51:187–92.
Castagneto B, Zai S, Marenco D, Bertetto O, Repetto L, et al. Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: response to treatment and correlation with the comprehensive geriatric assessment. Oncol 2004;67:27–32.
Tanvetyanon T, Choudhury AM. Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade. J Urol 2004;171:1627.
Wright JL, Lin DW, Dewan P, Montgomery RB. Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer. Int J Urol 2005;12:1012–3.
Jordan Feld MD, Hitesh Mehta MD, Ronald L, Burkes MD. Acute spontaneous tumor lysis syndrome in adenocarcinoma of the lung. Am J Clin Oncol (CCT) 2000;23:491–3.
Sklarin NT, Markham M. Spontaneous recurrent tumor lysis syndrome in breast cancer. Am J Clin Oncol (CCT) 1995;18:71–3.
Tomlinson G, Solberg LA. Acute tumor lysis syndrome with metastatic medulloblastoma. Cancer 1984;53:1783–5.